XML 39 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Background (Details)
$ / shares in Units, $ in Millions
9 Months Ended
Jun. 22, 2025
USD ($)
Sep. 30, 2025
USD ($)
employee
$ / shares
Sep. 16, 2025
USD ($)
Aug. 29, 2025
USD ($)
Dec. 31, 2024
$ / shares
Background          
Common stock, par value (in dollars per share) | $ / shares   $ 0.001     $ 0.001
Recognized as receivable for termination fees $ 1.3        
OrthoCellix Inc | Combined Company          
Background          
Termination fee 0.8        
Concurrent investment amount 25.0        
concurrent financing amount     $ 25.0    
Out of pocket expenses incurred 0.5        
Ocugen Inc | Combined Company          
Background          
Concurrent investment amount $ 5.0     $ 5.0  
Employee Severance | Cash Preservation Plan, 2025          
Background          
Reduction in workforce, number of employees | employee   37      
Reduction in workforce (as a percent)   84.00%      
Restructuring charges   $ 4.2